Free Trial

CRISPR Therapeutics (CRSP) SEC Filings & 10K Form

CRISPR Therapeutics logo
$58.00 +0.32 (+0.55%)
As of 01:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent CRISPR Therapeutics SEC Filings

DateFilerForm TypeView
07/17/2025
6:44 PM
BlackRock, Inc. (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G
06/26/2025
6:08 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2025
4:31 PM
CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
Form 3/A
06/06/2025
4:38 PM
Behbahani Ali (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:47 PM
CRISPR Therapeutics (Issuer)
George Simeon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:20 PM
CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
High Katherine A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Fardis Maria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Mahatme Sandesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Fleming Harold Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Rommel Christian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
4:30 PM
CRISPR Therapeutics (Issuer)
Morrison Briggs (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:45 PM
CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:45 PM
CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
9:52 AM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
05/13/2025
4:53 PM
Capital International Investors (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
03/24/2025
4:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:05 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:05 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
6:05 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Greene John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
4:35 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
10:23 AM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
01/10/2025
8:23 PM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SCHEDULE 13G/A
12/27/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
12:34 PM
ARK Investment Management LLC (Filed by)
CRISPR Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
8:05 AM
CRISPR Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
11/05/2024
8:10 AM
CRISPR Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Prasad Raju (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM
CRISPR Therapeutics (Issuer)
Patel Naimish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM
Bruno Julianne (Reporting)
CRISPR Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
4:35 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
5:00 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
5:00 PM
CRISPR Therapeutics (Issuer)
KASINGER JAMES R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
5:45 PM
CRISPR Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:22 PM
CRISPR Therapeutics (Filer)
Form S-3ASR
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRSP) was last updated on 7/31/2025 by MarketBeat.com Staff
From Our Partners